Basis: Trailing twelve months (TTM). Source: stored company filings and market data; unavailable inputs remain N/A.
The enterprise value (EV) is $6.04B.
ENTERPRISE VALUE (EV)
$6.04B
Alkermes plc
Market Cap
$7.15B
Enterprise Value (EV)
$6.04B
| NAME | MARKET CAP | ENTERPRISE VALUE (EV) |
|---|---|---|
| Alkermes plc (ALKS) | $7.15B | $6.04B |
| Ionis Pharmaceuticals, Inc. (IONS)vs › | $7.34B | $9.41B |
| Immunovant, Inc. (IMVT)vs › | $6.96B | $6.16B |
| GRAIL Inc. (GRAL)vs › | $6.85B | $6.89B |
| Chemed Corporation (CHE)vs › | $6.71B | $7.00B |
| Hims & Hers Health, Inc. (HIMS)vs › | $6.69B | $7.63B |
| HealthEquity, Inc. (HQY)vs › | $7.65B | $8.37B |
| Hinge Health, Inc. (HNGE)vs › | $7.66B | $7.38B |
| Cytokinetics, Incorporated (CYTK)vs › | $7.73B | $8.74B |
| Amneal Pharmaceuticals, Inc. (AMRX)vs › | $6.52B | $9.18B |
Market Cap
$7.15B
Total Debt
$6.75M
Cash
$1.12B
Enterprise Value
$6.04B
Why use EV instead of Market Cap?
Enterprise Value represents the total value of a company as if you were to acquire it completely - paying for equity while assuming debt and receiving cash.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
